Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125635033 | 12563503 | 3 | F | 2015 | 20160812 | 20160715 | 20160818 | EXP | CA-ABBVIE-15P-028-1500339-00 | ABBVIE | 0.00 | F | Y | 42.00000 | KG | 20160818 | MD | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125635033 | 12563503 | 1 | PS | KALETRA | LOPINAVIRRITONAVIR | 1 | Oral | DAILY DOSE: 800MG/200MG; UNIT DOSE: 400MG/100MG; FORM STRENGTH: 200MG/50MG | UNKNOWN | 21906 | 2 | DF | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125635033 | 12563503 | 1 | Antiretroviral therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125635033 | 12563503 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125635033 | 12563503 | Decreased appetite | |
| 125635033 | 12563503 | Exposure during pregnancy | |
| 125635033 | 12563503 | Nausea | |
| 125635033 | 12563503 | Normal newborn | |
| 125635033 | 12563503 | Prolonged labour | |
| 125635033 | 12563503 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125635033 | 12563503 | 1 | 20131006 | 0 |